Raymond J. Wiacek

JonesDay
Raymond J. Wiacek (Ray)
Partner
Practice Leader
Tax
Ray Wiacek's practice involves the tax and business aspects of financial and international transactions, including structured and cross-border financings, mergers and acquisitions, transfer pricing, and international licensing and related planning for intellectual property, as well as disputes with the IRS and foreign governments related to such transactions. He oversees the Firm's global Tax Practice.

Ray led the worldwide team integrating Warner-Lambert and Pharmacia with Pfizer after Pfizer's acquisition of those companies. This included the disposition of nonstrategic assets, such as Schick and Wilkinson Sword to Energizer and Chiclets and Dentyne to Cadbury. He recently negotiated and closed a number of cross-border financings for Bank of America, against many of the leading banks in Europe. He also has favorably resolved tax disputes ranging from the proper pricing of foreign autos and trucks to the validity of synfuel credits and from the effectiveness of an agreement to share R&D costs worldwide to the tax treatment of M&A break up fees.

In addition to Bank of America and Pfizer, representative clients include Bridgestone/Firestone, Dow Corning, Isuzu Motors, Morgan Stanley, Transworld Oil, and United Coal.

Ray has testified on behalf of U.S. multinational corporations with respect to international tax matters before the House Ways and Means Committee, the Senate Finance Committee, the Senate Foreign Relations Committee, and the Internal Revenue Service. He also has served as an adjunct tax professor at Georgetown University Law Center. He is a speaker at forums such as the Institute on Current Issues in International Taxation.

Experience


Pfizer reaches agreement with Boehringer Ingelheim to divest animal health assets in connection with regulatory approval process
Jones Day represented Pfizer Inc. in its recently announced agreement with Boehringer Ingelheim to divest certain animal health assets in connection with the regulatory approval process associated with Pfizer's pending acquisition of Wyeth.

Pfizer sells consumer healthcare business to Johnson & Johnson for $16.6 billion
Jones Day represented Pfizer, Inc., the world's largest pharmaceutical company, in the sale of its consumer healthcare business to Johnson & Johnson for $16.6 billion cash.

Isuzu Motors America sells DMAX interest to GM Corp.
Jones Day advised Isuzu Motors America, Inc. in its $150 million sale of commercial vehicle assets and membership interest in DMAX, a joint venture between Isuzu Motors America and General Motors to develop high-end diesel engines, to an affiliate of Isuzu Motors America in connection with a corporate restructuring.

Ernst & Young International sells management consulting business to Cap Gemini Group for $11.7 billion
Jones Day advised Ernst & Young in the $11.7 billion merger of its consulting business with Cap Gemini, the French technology services group.


Publications

August 20, 2007
Attorney Recommends Changes to U.S. Foreign Tax Credit Generator Regs, Tax Notes International
July/August 2007
Zealotry and the new FTC regulations, International Tax Review - PDF Only
Speaking Engagements

September 30, 2010
2010 Transaction Update
July 23, 2009
International Business Roundtable: Pittsburgh in the Global Economy - Doing Business in Europe, Asia, Mexico, and the Middle East Pittsburgh, Pennsylvania

Areas of Focus

Tax
Banking & Finance
International Taxation
Mergers & Acquisitions Taxation
Structured Finance Taxation

Honors & Distinctions

Listed as a leading lawyer in Chambers USA in each year of its publication; also listed in Euromoney's International Tax Review, Best Lawyers in America, Super Lawyers, and Who's Who Legal


Education

Harvard University (J.D. cum laude 1976); Yale University (B.A. summa cum laude 1973; Phi Beta Kappa)

Bar Admissions

District of Columbia